Affymax

Affymax

closed
Innovative biopharmaceutical solutions addressing unmet medical needs in hematology and oncology. Learn more

Employees
Market cap
€2.6m
Enterprise valuation
(€466k) (Public information from Sep 2024)
Palo Alto California (HQ)
Authorizing premium user...